Adrian L Rabinowicz Selected Research

Tablets

1/2015

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian L Rabinowicz Research Topics

Disease

12	Epilepsy (Aura) 01/2022 - 10/2014
6	Seizures (Absence Seizure) 01/2022 - 10/2014
3	Hypertriglyceridemia 03/2017 - 03/2017
3	Multiple Sclerosis 11/2015 - 01/2015
2	Drug Resistant Epilepsy 01/2022 - 10/2018
2	Hypersensitivity (Allergy) 10/2021 - 01/2021
2	Rhinitis 10/2021 - 01/2021
2	Urinary Tract Infections (Urinary Tract Infection) 03/2015 - 01/2015
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Migraine Disorders (Migraine) 12/2021
1	Sleepiness 01/2020
1	Hemolytic Anemia 01/2020
1	Generalized Epilepsy 01/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Pain (Aches) 01/2018
1	Cerebral Palsy (Spastic Diplegia) 02/2017
1	Ischemic Stroke 11/2015
1	Headache (Headaches) 01/2015
1	Nausea 01/2015
1	Dizziness (Lightheadedness) 01/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2004

Drug/Important Bio-Agent (IBA)

12	Diazepam (Valium)FDA LinkGeneric 01/2022 - 10/2014
11	Nasal SpraysIBA 01/2022 - 10/2014
5	4-Aminopyridine (4 Aminopyridine)FDA Link 02/2017 - 01/2015
3	BenzodiazepinesIBA 10/2021 - 01/2021
3	Pharmaceutical PreparationsIBA 01/2021 - 11/2015
3	Docosahexaenoic AcidsIBA 10/2018 - 03/2017
2	dodecyl maltosideIBA 12/2021 - 01/2021
2	Eicosapentaenoic AcidIBA 10/2018 - 03/2017
1	Sumatriptan (Imigran)FDA LinkGeneric 12/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	docosahexaenoylascorbic acid (DHA-As)IBA 03/2017
1	Dietary Fats (Dietary Fat)IBA 03/2017
1	Prescription DrugsIBA 03/2017
1	AcidsIBA 03/2017
1	EstersIBA 03/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2017
1	TabletsIBA 01/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2004
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2004
1	Antipsychotic Agents (Antipsychotics)IBA 01/2004

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2004
1	Retreatment 01/2022
1	Intranasal Administration 01/2021
1	Duration of Therapy 01/2015